LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 0.35 | |
| Mar2024 | ₹32 Cr | -7.30 | |
| Mar2023 | ₹34 Cr | -20.24 | |
| Mar2022 | ₹43 Cr | 3.93 | |
| Mar2021 | ₹41 Cr | - | |
Compare Contingent Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹270.9 Cr | 0.5% | -8.7% | -50.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 0.5% |
-8.7% |
-50.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses